Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

VMD reports drug supply problems
The VMD has revealed that there are currently supply problems with a number of veterinary products. (Stock photo)
Directorate provides advice on alternative products 

The Veterinary Medicines Directorate (VMD) has revealed there are currently supply problems with a number of veterinary products, including leptospirosis vaccines for cattle and local anaesthetic products containing procaine hydrochloride.

Supply problems exist for the following products:

Vaccines for Leptospira hardjo and Leptospira borgpetersenii
There are supply issues with two leptospirosis vaccines authorised in the UK for use in cattle. Supply problems are expected to be resolved in October 2019. In the meantime, the VMD is accepting applications to import an EU alternative, BioBos L. injection suspension for cattle, which is licensed in the Czech Republic, and Spirovac, which is licensed in the USA.

Local anaesthetic products containing procaine hydrochloride
VMD said it is aware of UK availability issues with some of these products. Information on authorised products are available on the VMD’s product information database. Suppliers have advised that the UK authorised Pronestesic 40mg/ml / 0.036mg/ml Solution for Injection for Horses, Cattle, Pigs and Sheep, is available to meet present demand.

Viper Venom Antiserum for veterinary use (adder bite antivenom)
There are no viper venom antiserums licensed in the UK for treating adder bites in animals. VMD accepts applications to import European Viper Antiserum from Biomed (Poland) and the Institute of Immunology, Zagreb (Croatia). VMD said anyone wishing to import should contact the manufacturer before submitting an application to ensure they can supply the quantity needed.

In urgent cases, antivenom may be supplied, purchased and used prior to the special treatment certificate being obtained from the VMD.

ACP injection 10mg/ml solution for injection
This product is indicated for anaesthetic premedication, tranquillisation and sedation in horses. It is not known when stocks will be available. Applications are currently accepted to import this product for use in horses only. Two EU alternatives are available - Calmivet solution for injection (5mg/ml) and Vetranquil 1% solution for injection (10mg/ml).


For information on prescribing under the cascade, visit the VMD’s website.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.